Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors

Clinical and Experimental Applications of Sodium Phenylbutyrate

(2013) Tommaso Iannitti et al.   Drugs in research & development

Perinatal nicotine exposure induces asthma in second generation offspring

(2012) Virender K Rehan et al.   BMC Medicine

QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: A case report and review of the literature

(2012) Donald R. Lynch Jr et al.   Cardiology Journal

Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease

(2012) Nambirajan Govindarajan et al.   EMBO Molecular Medicine

HDAC1 Regulates Fear Extinction in Mice

(2012) S. Bahari-Javan et al.   JOURNAL OF NEUROSCIENCE

Genome-wide profiling of multiple histone methylations in olfactory cells: further implications for cellular susceptibility to oxidative stress in schizophrenia

(2012) S Kano et al.   MOLECULAR PSYCHIATRY

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

(2012) S Miyamoto et al.   MOLECULAR PSYCHIATRY

An epigenetic blockade of cognitive functions in the neurodegenerating brain

(2012) Johannes Gräff et al.   NATURE

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

(2012) Mitsumasa Kurita et al.   NATURE NEUROSCIENCE

Chromatin replication and epigenome maintenance

(2012) Constance Alabert et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate molecules

(2012) Akihiro Mouri et al.   NEUROBIOLOGY OF DISEASE

Early Cognitive Experience Prevents Adult Deficits in a Neurodevelopmental Schizophrenia Model

(2012) Heekyung Lee et al.   NEURON

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

(2012) Alkomiet Hasan et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

(2012) Alkomiet Hasan et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Schizophrenia: Treatment Targets Beyond Monoamine Systems

(2011) Hisham M. Ibrahim et al.   Annual Review of Pharmacology and Toxicology

Epigenetic Signatures of Autism

(2011) Hennady P. Shulha   ARCHIVES OF GENERAL PSYCHIATRY

Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation

(2011) Alkomiet Hasan et al.   BEHAVIOURAL BRAIN RESEARCH

The human histone H3 complement anno 2011

(2011) Thomas H.A. Ederveen et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Are There Progressive Brain Changes in Schizophrenia? A Meta-Analysis of Structural Magnetic Resonance Imaging Studies

(2011) Bayanne Olabi et al.   BIOLOGICAL PSYCHIATRY

SIRT1 Activates MAO-A in the Brain to Mediate Anxiety and Exploratory Drive

(2011) Sergiy Libert et al.   CELL

Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modification

(2011) Minjia Tan et al.   CELL

Chromatin higher-order structures and gene regulation

(2011) Guohong Li et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Schizophrenia as a disorder of disconnectivity

(2011) Andrea Schmitt et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Quetiapine for bipolar depression

(2011) Alberto Chiesa et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Tissue-specific Distribution and Dynamic Changes of 5-Hydroxymethylcytosine in Mammalian Genomes

(2011) Shannon Morey Kinney et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Role of HDACs Inhibitors in Childhood and Adolescence Acute Leukemias

(2011) Riccardo Masetti et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

HDAC3 Is a Critical Negative Regulator of Long-Term Memory Formation

(2011) S. C. McQuown et al.   JOURNAL OF NEUROSCIENCE

‘The missing genes: what happened to the heritability of psychiatric disorders?’

(2011) T J Crow   MOLECULAR PSYCHIATRY

Cancer epigenetics reaches mainstream oncology

(2011) Manuel Rodríguez-Paredes et al.   NATURE MEDICINE

HDAC3 and the molecular brake pad hypothesis

(2011) Susan C. McQuown et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

Hippocampal Focal Knockout of CBP Affects Specific Histone Modifications, Long-Term Potentiation and Long-Term Memory

(2011) Ruth M Barrett et al.   NEUROPSYCHOPHARMACOLOGY

Evidence that clozapine directly interacts on the GABAB receptor

(2011) Ying Wu et al.   NEUROREPORT

Hypoxia-Induced Down-Regulation of Neprilysin by Histone Modification in Mouse Primary Cortical and Hippocampal Neurons

(2011) Zheng Wang et al.   PLoS One

Epigenetic Alterations Are Critical for Fear Memory Consolidation and Synaptic Plasticity in the Lateral Amygdala

(2011) Melissa S. Monsey et al.   PLoS One

Histone fold modifications control nucleosome unwrapping and disassembly

(2011) M. Simon et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Is obsessive–compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective

(2011) O. J. Bienvenu et al.   PSYCHOLOGICAL MEDICINE

Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders

(2011) B Tang et al.   Translational Psychiatry

Linking Molecules to Mood: New Insight Into the Biology of Depression

(2010) Vaishnav Krishnan et al.   AMERICAN JOURNAL OF PSYCHIATRY

Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis

(2010) Jorge M. Tamayo et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

High content analysis of histone acetylation in human cells and tissues

(2010) Pritika J. Narayan et al.   JOURNAL OF NEUROSCIENCE METHODS

Prefrontal GABAA receptor α-subunit expression in normal postnatal human development and schizophrenia

(2010) Carlotta E. Duncan et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Charting histone modifications and the functional organization of mammalian genomes

(2010) Vicky W. Zhou et al.   NATURE REVIEWS GENETICS

Epigenetic GABAergic targets in schizophrenia and bipolar disorder

(2010) A. Guidotti et al.   NEUROPHARMACOLOGY

Spatial Memory Consolidation is Associated with Induction of Several Lysine-Acetyltransferase (Histone Acetyltransferase) Expression Levels and H2B/H4 Acetylation-Dependent Transcriptional Events in the Rat Hippocampus

(2010) Olivier Bousiges et al.   NEUROPSYCHOPHARMACOLOGY

The treatment of cognitive impairment in schizophrenia

(2010) Donald C. Goff et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Altered Histone Acetylation Is Associated with Age-Dependent Memory Impairment in Mice

(2010) S. Peleg et al.   SCIENCE

Targeting the correct HDAC(s) to treat cognitive disorders

(2010) André Fischer et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The epigenetic bottleneck of neurodegenerative and psychiatric diseases

(2009) Farahnaz Sananbenesi et al.   BIOLOGICAL CHEMISTRY

Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study

(2009) Emre Bora et al.   BRITISH JOURNAL OF PSYCHIATRY

Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks

(2009) D. Palmieri et al.   CLINICAL CANCER RESEARCH

Creating zinc monkey wrenches in the treatment of epigenetic disorders

(2009) Jay Hans Kalin et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Histone deacetylase inhibitors: A new perspective for the treatment of leukemia

(2009) Ana Lucia Abujamra et al.   LEUKEMIA RESEARCH

Is There a Future for Histone Deacetylase Inhibitors in the Pharmacotherapy of Psychiatric Disorders?

(2009) D. R. Grayson et al.   MOLECULAR PHARMACOLOGY

HDAC2 negatively regulates memory formation and synaptic plasticity

(2009) Ji-Song Guan et al.   NATURE

GABAA receptors and their associated proteins: Implications in the etiology and treatment of schizophrenia and related disorders

(2009) Erik I. Charych et al.   NEUROPHARMACOLOGY

Neurocognition in first-episode schizophrenia: A meta-analytic review.

(2009) Raquelle I. Mesholam-Gately et al.   NEUROPSYCHOLOGY

Amygdalocortical Circuitry in Schizophrenia: From Circuits to Molecules

(2009) Francine M Benes   NEUROPSYCHOPHARMACOLOGY

The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements

(2009) R. W. Buchanan et al.   SCHIZOPHRENIA BULLETIN

Epigenomic Profiling Reveals DNA-Methylation Changes Associated with Major Psychosis

(2008) Jonathan Mill et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Conserved Regional Patterns of GABA-Related Transcript Expression in the Neocortex of Subjects With Schizophrenia

(2008) Takanori Hashimoto et al.   AMERICAN JOURNAL OF PSYCHIATRY

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

(2008) Nagma Khan et al.   BIOCHEMICAL JOURNAL

Extinction Memory Is Impaired in Schizophrenia

(2008) Daphne J. Holt et al.   BIOLOGICAL PSYCHIATRY

Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia

(2008) Tsung-Ung W. Woo et al.   BRAIN RESEARCH

Histone Deacetylase Inhibitors: Therapeutic Agents and Research Tools for Deciphering Motor Neuron Diseases

(2008) A. Echaniz-Laguna et al.   CURRENT MEDICINAL CHEMISTRY

GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability

(2008) Erminio Costa et al.   Expert Review of Neurotherapeutics

Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis

(2008) Daniel Martins-de-Souza et al.   JOURNAL OF NEURAL TRANSMISSION

Synergistic Neuroprotective Effects of Lithium and Valproic Acid or Other Histone Deacetylase Inhibitors in Neurons: Roles of Glycogen Synthase Kinase-3 Inhibition

(2008) Y. Leng et al.   JOURNAL OF NEUROSCIENCE

The Reelin and GAD67 Promoters Are Activated by Epigenetic Drugs That Facilitate the Disruption of Local Repressor Complexes

(2008) M. Kundakovic et al.   MOLECULAR PHARMACOLOGY

Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

(2008) Aleksey G. Kazantsev et al.   NATURE REVIEWS DRUG DISCOVERY

Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation

(2008) E. Dong et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects

(2008) David P. Gavin et al.   SCHIZOPHRENIA RESEARCH

Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology

(2008) R TANDON et al.   SCHIZOPHRENIA RESEARCH

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL

Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: Analysis of the National Brain Databank microarray collection

(2007) Rajiv P. Sharma et al.   SCHIZOPHRENIA RESEARCH